Khalid Y. Alkhatib

Alfaisal University, Brigham and Women's Hospital

Papers

2

Total Citations

13

H-Index

2

About

Dr. Khalid Y. Alkhatib is a urologic surgeon and researcher whose work focuses on advancing the surgical management of genitourinary cancers, particularly renal cell carcinoma (RCC) and testicular cancer. His major contributions include analyzing contemporary trends in RCC treatment, where his most-cited paper (8 citations) highlights how increased radiological detection of small renal masses has shifted surgical practices and improved survival outcomes in tertiary care settings. In testicular cancer, Dr. Alkhatib has provided crucial updates on open retroperitoneal lymph node dissection (O-RPLND), a cornerstone of multimodal therapy. His 2024 study (5 citations) delivers the first contemporary perioperative outcomes for this procedure in over a decade, offering essential benchmarks for safety and efficacy. By documenting modern surgical trends and outcomes, his work helps bridge the gap between historical data and current clinical realities, guiding evidence-based decision-making for complex urologic oncology cases. Dr. Alkhatib’s research is particularly valuable for trainees and clinicians seeking up-to-date, real-world insights into the evolving landscape of cancer surgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
13
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Trends in the surgical management of renal cell carcinoma in a contemporary tertiary care setting
8 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Alfaisal University, Brigham and Women's Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago